nivolumab
bms
['sclc', 'nadim,(-nadim-1),(-nadim1),(-nadim 1),(-nadim-i),(-nadimi),(-nadim i),(-nadim-2),(-nadim 2),(-nadim2)', 'nsclc']
educational session #esmo22 perioperative immunotherapy for early-stage nsclc by reviewing #nadim data. ps:"never stop dreaming" 
GECP/SLCG
Desde 1991 investigando para avanzar en curación y supervivencia al #cancerdepulmon 
#LungResearch #GECPResearch #CancerResearch